Shasun gets MHRA OK; Haupt invests in German plant; Yusen adds warehousing in Thailand;

> India's Shasun Pharmaceuticals passed a cGMP inspection by the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) for a formulation plant in India. Release (PDF)

> Munster, Germany-based CMO Haupt has invested €15 million ($19.8 million) in its manufacturing plant in preparation to make oral contraceptives for an unnamed client. Story

> Logistics company Yusen has opened a 40,000-square-meter warehouse in Laem Chabang, Thailand. Item

> The FDA has sent a warning letter to the Jabones Pardo plant in Madrid, Spain. Letter

> The FDA has sent a warning letter to Stewart Compounding Pharmacy in Fayetteville, NC. Letter

> India's Union Health Ministry is looking to amend rules to require drugmakers to hold records and samples longer as part of an effort to upgrade manufacturing quality. Story